v3.26.1
Stock Options
 3 Months Ended
Jan. 31, 2026
Stock Options [Abstract]  
STOCK OPTIONS

NOTE 8: STOCK OPTIONS

 

The 2018 Equity Incentive Plan was approved by the Board of Directors on July 1, 2018 and the Company amended the equity plan on December 17, 2023. In conjunction with the recapitalization and effective January 3, 2024, the Company adopted the Heliospace 2018 Equity Plan as the Company’s Plan (“Equity Plan”). On August 19, 2025, the Company adopted the Helio Corporation 2025 Equity Incentive Plan (the “2025 Plan”), which was also approved by the Company’s stockholders on August 19, 2025. The 2025 Plan is intended to assist the Company in recruiting and retaining employees, officers, directors, and consultants, and to provide incentives tied to increases in the value of the Company’s equity. Unless terminated earlier by the Board, the 2025 Plan will terminate on August 19, 2035, and no awards may be granted after that date.

The 2025 Equity Plan limits the shares of common stock authorized to be awarded as stock awards to 2,382,352 shares as of January 31, 2026 and October 31, 2025, respectively. Employees are provided stock options vesting over a period of four years with a one year cliff. After one year, 25% of the award size vests followed by 1/48th of the award size for each month thereafter. On a case-by-case basis, options have been granted outright with no vest period.

 

Due to the change-in-control transaction described in Note 1, there was a recapitalization for which the Company’s stock options were adjusted for the new capital structure. The Company adjusted each of the granted options a 0.612 factor.

 

During the three months ended January 31, 2026 and 2025, there were no stock options granted.

 

   Number of
Shares		   Weighted Average
Exercise
Price ($)		   Weighted
Average
Remaining
Term
(Three months)		   Aggregate
Intrinsic
Value		 
Three months ended January 31, 2025                
Balance as of October 31, 2024   1,422,307   $0.09    7.02   $6,980,951 
Issued   
-
    
-
    -    
-
 
Canceled   
-
    
-
    -    
-
 
Exercised   
-
    
-
    -    
-
 
Balance as of January 31, 2025   1,422,307   $0.09    6.77   $6,980,951 
Exercisable as of January 31, 2025   1,145,578   $0.09    6.42   $5,679,031 
                     
Three months ended January 31, 2026                    
Balance as of October 31, 2025   1,750,971   $0.43    6.73   $438,197 
Issued   
-
    
-
    -    
-
 
Canceled   
-
    
-
    -    
-
 
Exercised   
-
    
-
    -    
-
 
Balance as of January 31, 2026   1,750,971   $0.43    6.48   $1,618,854 
Exercisable as of January 31, 2026   1,635,980   $0.45    6.40   $1,491,702 

 

Stock-based compensation from stock awards for the three months ended January 31, 2026 and 2025 was $32,384 and $46,497, respectively. As of January 31, 2026 and October 31, 2025, there remained $78,597 and $110,981 of unrecognized stock-based compensation from stock option awards, respectively. As of January 31, 2026, there were 1,635,980 shares of common stock related to stock option grants that were vested and 114,991 stock option grants that were unvested.